Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

G Bjelakovic, D Nikolova, LL Gluud… - Cochrane database …, 2012 - cochranelibrary.com
Antioxidant supplements for prevention of mortality in healthy participants and patients with
various diseases - Bjelakovic, G - 2012 | Cochrane Library Skip to Content Cookies Our site …

Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines

JW Eikelboom, J Hirsh, FA Spencer, TP Baglin, JI Weitz - Chest, 2012 - Elsevier
The article describes the mechanisms of action, pharmacokinetics, and pharmacodynamics
of aspirin, dipyridamole, cilostazol, the thienopyridines, and the glycoprotein IIb/IIIa …

[HTML][HTML] Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis

SC Moore, AV Patel, CE Matthews… - PLoS …, 2012 - journals.plos.org
Leisure Time Physical Activity of Moderate to Vigorous Intensity and Mortality: A Large
Pooled Cohort Analysis | PLOS Medicine Skip to main content Advertisement PLOS …

Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence …

PO Vandvik, AM Lincoff, JM Gore, DD Gutterman… - Chest, 2012 - Elsevier
Background This guideline focuses on long-term administration of antithrombotic drugs
designed for primary and secondary prevention of cardiovascular disease, including two …

The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the …

JAE Manson, SS Bassuk, IM Lee, NR Cook… - Contemporary clinical …, 2012 - Elsevier
Data from laboratory studies, observational research, and/or secondary prevention trials
suggest that vitamin D and marine omega-3 fatty acids may reduce risk for cancer or …

Comparison of ischemic stroke incidence in HIV-infected and non–HIV-infected patients in a US health care system

FC Chow, S Regan, S Feske, JB Meigs… - JAIDS Journal of …, 2012 - journals.lww.com
Background: Cardiovascular disease is increased among HIV-infected patients, but little is
known regarding ischemic stroke rates. We sought to compare stroke rates and determine …

Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials

SRK Seshasai, S Wijesuriya… - Archives of internal …, 2012 - jamanetwork.com
Background The net benefit of aspirin in prevention of CVD and nonvascular events remains
unclear. Our objective was to assess the impact (and safety) of aspirin on vascular and …

Aspirin in the chemoprevention of colorectal neoplasia: an overview

AT Chan, N Arber, J Burn, WK Chia, P Elwood… - Cancer prevention …, 2012 - AACR
Considerable evidence supports the effectiveness of aspirin for chemoprevention of
colorectal cancer (CRC) in addition to its well-established benefits in the prevention of …

Meta-analysis of statin effects in women versus men

WJ Kostis, JQ Cheng, JM Dobrzynski, J Cabrera… - Journal of the American …, 2012 - jacc.org
Objectives: The aim of this study was to evaluate the effect of statins in decreasing
cardiovascular events in women and men. Background: Published data reviews have …

Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome

NS Gerstein, PM Schulman, WH Gerstein… - Annals of …, 2012 - journals.lww.com
Objective: To provide an evidence-based focused review of aspirin use in the perioperative
period along with an in-depth discussion of the considerations and risks associated with its …